{"disease":{"id":"squamous-cell-carcinoma-of-the-head-and-neck-t1-2n0-2","name":"squamous cell carcinoma of the head and neck t1 2n0 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02201355","title":"Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}